Beyond this, epigenetic modifiers (i.e., Methyltransferase, BET-domain, SWI/SNF, and Lysine Demethylase members) as well as known long non-coding (lnc) RNAs with a role in breast cancer progression and prognosis (i.e., MALAT1, HOTAIR1, MEG3) [54,55] have been found to be generally deregulated in both the LB and TN samples. This evidence concerns the gene MEG3 and breast carcinoma.